To report a case of a patient with ulcerative colitis and latent tuberculosis infection who developed a high-titer factor V inhibitor, highlighting the complexities of managing coexisting autoimmune and infectious conditions.
Key Findings:
The patient exhibited a high-titer factor V inhibitor, which is an uncommon complication associated with ulcerative colitis and latent tuberculosis infection.
Initial treatment strategies, including standard immunosuppressive therapies for ulcerative colitis, did not yield improvement in the patient's condition until the immunomodulatory treatment with IVIG was introduced.
Interpretation:
This case underscores the intricate interplay between autoimmune disorders and infectious diseases, particularly in patients with ulcerative colitis who may be at increased risk for developing coagulopathies. The presence of a factor V inhibitor complicates management and necessitates a tailored approach that considers both the autoimmune and infectious components of the patient's health. The successful use of IVIG in this case highlights its potential role in managing similar patients, although further studies are needed to establish guidelines for treatment in such complex scenarios.
Limitations:
The findings are based on a single case, which limits the ability to generalize the results to a broader population.
There is currently no gold standard for diagnosing latent tuberculosis infection, which may affect the accuracy of diagnosis and treatment strategies.
Conclusion:
Immunoglobulin therapy was effectively utilized in this case to manage the factor V inhibitors associated with the patient's underlying conditions, demonstrating the need for a multidisciplinary approach in treating patients with concurrent autoimmune and infectious diseases.
